account_id none on file
legal_name Xtl Biopharmaceuticals Ltd
ticker XTLB
cik 1023549
domain xtlbio.com
linkedin_company_url https://www.linkedin.com/company/xtl-biopharmaceuticals-ltd.
entry_point_account_id none on file
name XTL Biopharmaceuticals Ltd.
exchange Nasdaq
sector Health Care
hq New York, NY, United States
sector index/company/sector/health-care/
calls 0 filings 4 executives 0 family 0
why_nownone on file
callsnone on file
filings
address cost of living increases, recreation pay, travel expenses, vacation pay and other conditions of employment. We provide our employees
filing / Jun 30, 2026 / receipt
and expense reimbursement, save for one director who is eligible for fees for consulting services provided to the Company.
filing / Jun 30, 2026 / receipt
appointed our Chief Financial Officer in December 2025. Mr. Segal, CPA, has over 12 years of senior financial management experience, primarily
filing / Jun 30, 2026 / receipt
partnerships, and geographic expansion to maximize the commercial potential of our technologies. Enhancing our presence in high-demand regions such as the United States, Europe, and Asia.
filing / Jun 30, 2026 / receipt
executivesnone on file
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
slug xtl-biopharmaceuticals-ltd
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$